Contact Us

Covid-19 update

24th March 2020

Updated 25 June 

In view of the spread of Covid-19 (coronavirus) and the ever-changing responses by the UK, Europe and the rest of the world we continue to monitor the situation closely and will report any changes that affect our operations or those of the UK, European and US intellectual property offices. The downloadable pdf file below will be updated with developments as well as details of relief for clients affected by Covid-19.

Some automatic extensions are in place, and other requests for extensions are likely to be more favourably received than normal.  However, if you have a specific deadline that you feel you are unlikely to be able to meet in the current climate, then please contact us for advice.

Coronavirus update

Next Post

Backlash from patent applicants over stricter EPO description amendments
5th July 2022

In a first in a decision (T1989/18), of 16 December 2021, a Board of Appeal considered whether there was legal basis in the EPC for refusing a European patent application on the grounds that the description had not been amended to conform with the allowed claims.

Need some advice?

Call us on +44 (0) 115 947 7977 to speak to
one of our IP experts based in Nottingham, Leicester and London.

"By working with AdamsonJones we have been educated to understand the patentability of inventions, in turn guiding our product design and allowing us to make better strategic decisions."

"...prompt, hardworking and efficient patent attorney, who has quickly understood my client's pharmaceutical compound, patent portfolio and related compounds."

"...helped consolidate the patent potfolio to save the patent owner money and time."

"...legal expertise and thorough understanding of the commercial considerations and technology involved in our business."

"...we knew that they had the right expertise to help us maximise our value and be adequately prepared when the time came to sell."

"Their advice has proved reliable and effective and is always clear to follow."

Latest News
Backlash from patent applicants over stricter EPO description amendments
05th Jul 2022

In a first in a decision (T1989/18), of 16 December 2021, a Board of Appeal considered whether there was legal basis in the EPC for refusing a European patent application on the grounds that the description had not been amended to conform with the allowed claims.

Read More

Providing professional services of the highest quality

CIPA Logo Legal 500 Leading Firm 2020 CITMA Logo Medilink Logo IPReg Logo